| Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial A Osinusi, EG Meissner, YJ Lee, D Bon, L Heytens, A Nelson, M Sneller, ... Jama 310 (8), 804-811, 2013 | 398 | 2013 |
| Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection A Osinusi, K Townsend, A Kohli, A Nelson, C Seamon, EG Meissner, ... Jama 313 (12), 1232-1239, 2015 | 257 | 2015 |
| Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome EG Meissner, D Wu, A Osinusi, D Bon, K Virtaneva, D Sturdevant, ... The Journal of clinical investigation 124 (8), 3352-3363, 2014 | 229 | 2014 |
| BRCA1-associated growth arrest is RB-dependent ON Aprelikova, BS Fang, EG Meissner, S Cotter, M Campbell, A Kuthiala, ... Proceedings of the National Academy of Sciences 96 (21), 11866-11871, 1999 | 210 | 1999 |
| Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study A Kohli, A Osinusi, Z Sims, A Nelson, EG Meissner, LL Barrett, D Bon, ... The Lancet 385 (9973), 1107-1113, 2015 | 181 | 2015 |
| Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1–infected patients EG Meissner, YJ Lee, A Osinusi, Z Sims, J Qin, D Sturdevant, ... Hepatology 61 (3), 790-801, 2015 | 170 | 2015 |
| Simtuzumab treatment of advanced liver fibrosis in HIV and HCV‐infected adults: results of a 6‐month open‐label safety trial EG Meissner, M McLaughlin, L Matthews, AM Gharib, BJ Wood, E Levy, ... Liver International 36 (12), 1783-1792, 2016 | 110 | 2016 |
| Effect of subcutaneous casirivimab and imdevimab antibody combination vs placebo on development of symptomatic COVID-19 in early asymptomatic SARS-CoV-2 infection: a randomized … MP O’Brien, E Forleo-Neto, N Sarkar, F Isa, P Hou, KC Chan, BJ Musser, ... Jama 327 (5), 432-441, 2022 | 108 | 2022 |
| IFNL4-ΔG Genotype Is Associated With Slower Viral Clearance in Hepatitis C, Genotype-1 Patients Treated With Sofosbuvir and Ribavirin EG Meissner, D Bon, L Prokunina-Olsson, W Tang, H Masur, TR O'Brien, ... The Journal of infectious diseases 209 (11), 1700-1704, 2014 | 108 | 2014 |
| Re-treatment of chronic hepatitis C virus genotype 1 infection after relapse: an open-label pilot study A Osinusi, A Kohli, MM Marti, A Nelson, X Zhang, EG Meissner, R Silk, ... Annals of internal medicine 161 (9), 634-638, 2014 | 99 | 2014 |
| V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies MM Laakso, FH Lee, B Haggarty, C Agrawal, KM Nolan, M Biscone, ... PLoS pathogens 3 (8), e117, 2007 | 97 | 2007 |
| IFN-λ4 attenuates antiviral responses by enhancing negative regulation of IFN signaling AA Obajemu, N Rao, KA Dilley, JM Vargas, F Sheikh, RP Donnelly, ... The Journal of Immunology 199 (11), 3808-3820, 2017 | 69 | 2017 |
| Four-week direct-acting antiviral regimens in noncirrhotic patients with hepatitis C virus genotype 1 infection: an open-label, nonrandomized trial A Kohli, S Kattakuzhy, S Sidharthan, A Nelson, M McLaughlin, C Seamon, ... Annals of internal medicine 163 (12), 899-907, 2015 | 65 | 2015 |
| Disseminated microsporidiosis in an immunosuppressed patient EG Meissner, JE Bennett, Y Qvarnstrom, A da Silva, EY Chu, M Tsokos, ... Emerging infectious diseases 18 (7), 1155, 2012 | 61 | 2012 |
| Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelope EG Meissner, KM Duus, F Gao, XF Yu, L Su Virology 328 (1), 74-88, 2004 | 59 | 2004 |
| Magnetic resonance elastography shear wave velocity correlates with liver fibrosis and hepatic venous pressure gradient in adults with advanced liver disease AM Gharib, MAT Han, EG Meissner, DE Kleiner, X Zhao, M McLaughlin, ... BioMed Research International 2017 (1), 2067479, 2017 | 52 | 2017 |
| Interferon-free treatment of hepatitis C virus in HIV/hepatitis C virus-coinfected subjects results in increased serum low-density lipoprotein concentration K Townsend, EG Meissner, S Sidharthan, M Sampson, AT Remaley, ... AIDS research and human retroviruses 32 (5), 456-462, 2016 | 47 | 2016 |
| Achieving sustained virologic response after interferon‐free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis EG Meissner, A Kohli, K Virtaneva, D Sturdevant, C Martens, SF Porcella, ... Journal of viral hepatitis 23 (7), 496-505, 2016 | 45 | 2016 |
| Rapid changes in peripheral lymphocyte concentrations during interferon‐free treatment of chronic hepatitis C virus infection EG Meissner, A Kohli, J Higgins, YJ Lee, O Prokunina, D Wu, C Orr, ... Hepatology communications 1 (7), 586-594, 2017 | 43 | 2017 |
| Dynamic changes of post-translationally modified forms of CXCL10 and soluble DPP4 in HCV subjects receiving interferon-free therapy EG Meissner, J Decalf, A Casrouge, H Masur, S Kottilil, ML Albert, D Duffy PloS one 10 (7), e0133236, 2015 | 40 | 2015 |
